History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study
about
Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's diseaseCohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) studyCognitive impairment and dementia: a new emerging complication of type 2 diabetes-The diabetologist's perspective.Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with Alzheimer's disease (MEDALZ-2005) studyInsulin, cognition, and dementiaAmyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearanceLong term exendin-4 treatment reduces food intake and body weight and alters expression of brain homeostatic and reward markers.The Test Your Memory cognitive screening tool: sociodemographic and cardiometabolic risk correlates in a population-based study of older British men.Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies.Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology.Diabetes, glycaemia, and cognition-a secondary analysis of the Finnish Diabetes Prevention Study.Metabolic parameters and cognitive function in a cohort of older diabetic patients.The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain.Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.
P2860
Q26866392-7D1E6E81-E94F-423B-9A39-7D4FF07D4682Q28384359-78129661-6D30-4E7A-BADF-9E8AA906F127Q30235904-7D0076AF-4954-46CE-9EC6-ECD66FC3E06BQ30661806-0DD2B082-EA47-45A3-A1D2-3FCB9FC8AC65Q33604874-C06A2ABE-80E9-4F2C-9278-542C4ACACCB8Q34039695-E1B9C56D-7732-457B-910C-A52F775A8901Q34068305-A7116F8C-86EE-4328-86BA-C2CFCE03130FQ36866365-FABB8948-3B1F-489B-82B4-811B1376C957Q38344088-9A7C713B-A818-4E86-B501-28A52B861E29Q38974881-0E316E12-8EA5-464A-ADDD-DD8046DCD04DQ40739565-9550B25A-2E1C-47BB-A5A4-24A1113883BFQ41002434-CC555FDB-4E12-4DE6-AB6F-50C67DE96DCFQ47111896-645E25C7-ACAA-4528-AD4F-C80F45B59714Q52151966-F1868CDE-3FB2-4454-98E9-AEE69195F225
P2860
History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
History of medically treated d ...... nationwide case-control study
@en
type
label
History of medically treated d ...... nationwide case-control study
@en
prefLabel
History of medically treated d ...... nationwide case-control study
@en
P2860
P50
P356
P1433
P1476
History of medically treated d ...... nationwide case-control study
@en
P2093
Alina Solomon
Piia Lavikainen
P2860
P304
P356
10.2337/DC12-1287
P407
P577
2013-01-22T00:00:00Z